Skip to main content
. Author manuscript; available in PMC: 2012 Feb 17.
Published in final edited form as: Ann Thorac Surg. 2011 Sep;92(3):829–836. doi: 10.1016/j.athoracsur.2011.04.049

Table 2.

Data From Microarray Analysisa

Variable Fold
Changes		 −Log10 (p Value) Variable Fold
Changes		 −Log10 (p Value)
PLA2-G1B   0.20025   0.51986 PLC-β1 −0.14719 0.35611
PLA2-G2A −0.38263   0.85158 PLC-β2   0.108125 0.71506
PLA2-G4A   0.05025   0.38109 PLC-β3 −0.0045 0.5079
PLA2-G4C   0.150875   0.41136 PLC-β4   0.15325 0.47148
PLA2-G5 −0.23550   0.26525 PLC-γ1   0.036625 0.46310
PLA2-G6 −0.00167   0.7964 PLC-γ2 −0.05863 0.41421
PLA2-G7   0.092375   0.4245 PLC-δ1 −0.12919 0.601
PLA2-G10   0.032313   0.7037 PLC-ε1 −0.2055 0.38971
PLA2-G15   0.218188   0.63171 PLC-η1   0.05125 0.38601
PLA2-G16   0.051313   0.29672 PLC-η2   0.046625 0.40614
TXA-2 receptor −0.02581   0.59576 TXA-2 synthase   0.066 0.72305
MAPK-1   0.578313   0.88625 Rho-GEF-1 −0.03756 0.514944
MAPK-3 −0.41356   0.87362 Rho-GEF-2   0.215 0.531000
MAPK-4   0.057438   0.50662 Rho-GEF-4 −0.0745 0.645063
MAPK-6   0.452125   0.81766 Rho-GEF-5 −0.20275 0.554031
MAPK-7   0.1885   0.55187 Rho-GEF-7   0.190938 0.895394
MAPK-8 −0.03033   0.46150 Rho-GEF-10   0.087813 0.359363
MAPK-9   0.4345   0.75439 Rho-GEF-11   0.228375 0.710306
MAPK-10   0.176938   0.45802 Rho-GEF-12   0.042 0.545938
MAPK-11   0.058563   0.38492 Rho-GEF-15   0.0495 0.45661
MAPK-12 −0.0325   0.45474 Rho-GEF-16 −0.02125 0.63001
MAPK-13 −0.07294   0.44960 Rho-GEF-17   0.063563 0.40668
MAPK-14   0.3535   0.73609 Rho-GEF-18 −0.5015 0.94140
MTOR   0.33968   0.67460 Rho-A   0.183625 0.44555
PKC-α   0.159375   0.44953 PLD-1, PS −0.0155 0.460233
PKC-β   0.130625   0.45263 PLD-2   0.01825 0.442563
PKC-γ   0.0925   0.44668 PLD-3   0.635625 0.887557
GRK-1   0.50405   0.148125 GSK-β   0.253125 0.456617
GRK-4   0.55180 −0.05544 CaM-1-PK-δ −0.09713 0.630019
GRK-5   0.68997   0.074125 CaM-3-PK-δ   0.142563 0.406688
GRK-6   0.57186 −0.13606 Caldesmon 1   0.784933 0.941400
a

Microarray analysis showed no significant changes in the gene expression of TXA-2 receptors, TXA-2 synthase, PLC-γ1, or PLC-β3 after cardioplegic ischemia and reperfusion.

CaM-PK = calmodulin phosphorylase kinase; GRK = G protein–coupled receptor kinase; GSK = glycogen synthase kinase; MAPK = mitogen-activated protein kinase; MTOR = mammalian target of rapamycin; PKC = protein kinase C; PLA = phospholipase A; PLC = phospholipase C; PLD = phospholipase D; Rho-A = Ras homolog gene family, member A; Rho-GEF = Rho guanine nucleotide exchangefactor; TXA = thromboxane A.